Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcimark is an oral nutritional supplement developed and marketed by Ultramark Healthcare. It is typically formulated as a combination of calcium carbonate and cholecalciferol (Vitamin D3). Calcium is a vital mineral for bone formation and maintenance, while cholecalciferol facilitates the intestinal absorption of calcium and regulates phosphate metabolism. The product is indicated for the management of calcium and vitamin D deficiencies, supporting bone density in conditions like osteoporosis, osteomalacia, and rickets. It is distributed as a branded-generic pharmaceutical product in tablet form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium carbonate + cholecalciferol (Ultramark Healthcare).